CBIZ INC (CBZ)
US1248051021 - Common Stock
Taking everything into account, CBZ scores 5 out of 10 in our fundamental rating. CBZ was compared to 81 industry peers in the Professional Services industry. CBZ has an average financial health and profitability rating. CBZ is valued quite expensively, but it does show have an excellent growth rating. With these ratings, CBZ could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
CBZ had positive earnings in the past year.
CBZ had a positive operating cash flow in the past year.
Each year in the past 5 years CBZ has been profitable.
CBZ had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 5.58%, CBZ is doing good in the industry, outperforming 60.26% of the companies in the same industry.
With a decent Return On Equity value of 12.83%, CBZ is doing good in the industry, outperforming 60.26% of the companies in the same industry.
CBZ's Return On Invested Capital of 7.15% is in line compared to the rest of the industry. CBZ outperforms 51.28% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CBZ is significantly below the industry average of 17.86%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.58% | ||
| ROE | 12.83% | ||
| ROIC | 7.15% |
ROA(3y)5.29%
ROA(5y)5.22%
ROE(3y)13.37%
ROE(5y)12.4%
ROIC(3y)7.99%
ROIC(5y)7.14%
1.3 Margins
The Profit Margin of CBZ (7.08%) is better than 73.08% of its industry peers.
CBZ's Profit Margin has improved in the last couple of years.
CBZ's Operating Margin of 9.71% is fine compared to the rest of the industry. CBZ outperforms 71.79% of its industry peers.
CBZ's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 13.83%, CBZ is not doing good in the industry: 89.74% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CBZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.71% | ||
| PM (TTM) | 7.08% | ||
| GM | 13.83% |
OM growth 3Y3.37%
OM growth 5Y1.08%
PM growth 3Y-2.18%
PM growth 5Y2.62%
GM growth 3Y-0.52%
GM growth 5Y-0.19%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CBZ is destroying value.
The number of shares outstanding for CBZ has been reduced compared to 1 year ago.
Compared to 5 years ago, CBZ has less shares outstanding
Compared to 1 year ago, CBZ has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.87 indicates that CBZ is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.87, CBZ is doing good in the industry, outperforming 69.23% of the companies in the same industry.
CBZ has a debt to FCF ratio of 2.24. This is a good value and a sign of high solvency as CBZ would need 2.24 years to pay back of all of its debts.
The Debt to FCF ratio of CBZ (2.24) is better than 70.51% of its industry peers.
CBZ has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CBZ (0.36) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 2.24 | ||
| Altman-Z | 3.87 |
ROIC/WACC0.76
WACC9.46%
2.3 Liquidity
CBZ has a Current Ratio of 1.49. This is a normal value and indicates that CBZ is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CBZ (1.49) is comparable to the rest of the industry.
CBZ has a Quick Ratio of 1.49. This is a normal value and indicates that CBZ is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.49, CBZ perfoms like the industry average, outperforming 51.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.49 | ||
| Quick Ratio | 1.49 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.73% over the past year.
Measured over the past years, CBZ shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.90% on average per year.
CBZ shows a small growth in Revenue. In the last year, the Revenue has grown by 7.83%.
CBZ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.53% yearly.
EPS 1Y (TTM)3.73%
EPS 3Y19.07%
EPS 5Y16.9%
EPS Q2Q%25.37%
Revenue 1Y (TTM)7.83%
Revenue growth 3Y18.19%
Revenue growth 5Y11.53%
Sales Q2Q%6.9%
3.2 Future
CBZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.11% yearly.
The Revenue is expected to grow by 20.61% on average over the next years. This is a very strong growth
EPS Next Y13.09%
EPS Next 2Y14.23%
EPS Next 3Y13.11%
EPS Next 5YN/A
Revenue Next Year11.9%
Revenue Next 2Y18.53%
Revenue Next 3Y20.61%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 32.92, CBZ can be considered very expensive at the moment.
CBZ's Price/Earnings ratio is a bit more expensive when compared to the industry. CBZ is more expensive than 65.38% of the companies in the same industry.
CBZ's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.54.
CBZ is valuated quite expensively with a Price/Forward Earnings ratio of 26.50.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBZ is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.99. CBZ is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.92 | ||
| Fwd PE | 26.5 |
4.2 Price Multiples
62.82% of the companies in the same industry are cheaper than CBZ, based on the Enterprise Value to EBITDA ratio.
CBZ's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.4 | ||
| EV/EBITDA | 22.2 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of CBZ may justify a higher PE ratio.
A more expensive valuation may be justified as CBZ's earnings are expected to grow with 13.11% in the coming years.
PEG (NY)2.51
PEG (5Y)1.95
EPS Next 2Y14.23%
EPS Next 3Y13.11%
5. Dividend
5.1 Amount
No dividends for CBZ!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CBIZ INC
NYSE:CBZ (12/26/2024, 1:39:04 PM)
82.31
+0.02 (+0.02%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners93.04%
Inst Owner Change-4.59%
Ins Owners4.57%
Ins Owner Change-0.03%
Market Cap4.13B
Analysts85.71
Price Target98.94 (20.2%)
Short Float %2.61%
Short Ratio3.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.79%
Min EPS beat(2)-43.49%
Max EPS beat(2)9.91%
EPS beat(4)3
Avg EPS beat(4)-7.04%
Min EPS beat(4)-43.49%
Max EPS beat(4)9.91%
EPS beat(8)5
Avg EPS beat(8)-3.62%
EPS beat(12)8
Avg EPS beat(12)-7.05%
EPS beat(16)12
Avg EPS beat(16)7.45%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)-1.62%
Revenue beat(4)1
Avg Revenue beat(4)0.33%
Min Revenue beat(4)-1.71%
Max Revenue beat(4)4.95%
Revenue beat(8)5
Avg Revenue beat(8)1.55%
Revenue beat(12)9
Avg Revenue beat(12)3.24%
Revenue beat(16)13
Avg Revenue beat(16)3.8%
PT rev (1m)16.87%
PT rev (3m)16.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.52%
EPS NY rev (1m)0%
EPS NY rev (3m)0.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)15.35%
Revenue NY rev (1m)3.13%
Revenue NY rev (3m)-17.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.92 | ||
| Fwd PE | 26.5 | ||
| P/S | 2.46 | ||
| P/FCF | 27.4 | ||
| P/OCF | 25.13 | ||
| P/B | 4.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.2 |
EPS(TTM)2.5
EY3.04%
EPS(NY)3.11
Fwd EY3.77%
FCF(TTM)3
FCFY3.65%
OCF(TTM)3.28
OCFY3.98%
SpS33.49
BVpS18.49
TBVpS-2.04
PEG (NY)2.51
PEG (5Y)1.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.58% | ||
| ROE | 12.83% | ||
| ROCE | 9.71% | ||
| ROIC | 7.15% | ||
| ROICexc | 7.16% | ||
| ROICexgc | 18.51% | ||
| OM | 9.71% | ||
| PM (TTM) | 7.08% | ||
| GM | 13.83% | ||
| FCFM | 8.97% |
ROA(3y)5.29%
ROA(5y)5.22%
ROE(3y)13.37%
ROE(5y)12.4%
ROIC(3y)7.99%
ROIC(5y)7.14%
ROICexc(3y)8.02%
ROICexc(5y)7.16%
ROICexgc(3y)25.65%
ROICexgc(5y)22.16%
ROCE(3y)10.86%
ROCE(5y)9.7%
ROICexcg growth 3Y9.81%
ROICexcg growth 5Y-4.54%
ROICexc growth 3Y10.61%
ROICexc growth 5Y0.58%
OM growth 3Y3.37%
OM growth 5Y1.08%
PM growth 3Y-2.18%
PM growth 5Y2.62%
GM growth 3Y-0.52%
GM growth 5Y-0.19%
F-Score7
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 2.24 | ||
| Debt/EBITDA | 1.68 | ||
| Cap/Depr | 36.06% | ||
| Cap/Sales | 0.81% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.74% | ||
| Profit Quality | 126.66% | ||
| Current Ratio | 1.49 | ||
| Quick Ratio | 1.49 | ||
| Altman-Z | 3.87 |
F-Score7
WACC9.46%
ROIC/WACC0.76
Cap/Depr(3y)40.97%
Cap/Depr(5y)47.09%
Cap/Sales(3y)0.96%
Cap/Sales(5y)1.11%
Profit Quality(3y)130.56%
Profit Quality(5y)136.72%
High Growth Momentum
Growth
EPS 1Y (TTM)3.73%
EPS 3Y19.07%
EPS 5Y16.9%
EPS Q2Q%25.37%
EPS Next Y13.09%
EPS Next 2Y14.23%
EPS Next 3Y13.11%
EPS Next 5YN/A
Revenue 1Y (TTM)7.83%
Revenue growth 3Y18.19%
Revenue growth 5Y11.53%
Sales Q2Q%6.9%
Revenue Next Year11.9%
Revenue Next 2Y18.53%
Revenue Next 3Y20.61%
Revenue Next 5YN/A
EBIT growth 1Y-7.69%
EBIT growth 3Y22.16%
EBIT growth 5Y12.74%
EBIT Next Year27.2%
EBIT Next 3Y30.62%
EBIT Next 5YN/A
FCF growth 1Y48.23%
FCF growth 3Y-1.18%
FCF growth 5Y7.56%
OCF growth 1Y49.11%
OCF growth 3Y1.5%
OCF growth 5Y7.85%